RS5-13853-08311
3 vaccinations
4 coded responses
33 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 926 / CA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-20
Dose 1 — Pfizer-BioNTech
-
2020-12-21
Registered in v-safe
- 2020-12-21
- 2020-12-22
- 2020-12-26
- 2020-12-27
- 2021-01-04
- 2021-01-10
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-14
- 2021-01-15
- 2021-01-16
-
2021-01-17
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: Fair · HeadacheFree text: Known migraine headache and having my usual migraine (2nd in 3 days).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
-
2021-01-19
Survey response — day 7, dose 2MedDRA: Migraine — Feeling: Fair · Headache, NauseaFree text: Usual known migraine headache symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
-
2021-04-13
Survey response — 3 months, dose 2MedDRA: Muscle spasms, Office visit, Rash — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Rash after camping · Healthcare visit (other): DermatologyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-09
- 2021-07-16
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-03
- 2021-10-04
- 2021-10-07
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-14
- 2021-12-31
-
2022-04-03
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-04-03
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-06
Call successfulDoes not wish to fill out VAERS report
- 2022-10-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Call center
3 call center cases
2 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Known migraine headache and having my usual migraine (2nd in 3 days).
Release 2 — day 7, dose 2
Systemic reaction (other): Usual known migraine headache symptoms.
Release 7 — 3 months, dose 2
Release 11 — 6 months, dose 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Muscle spasms | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release